As a foundation for a discussion of the development and use of therapeutic
radiopharmaceuticals, it is first necessary to provide an introduction to the field of nuclear …

Four criteria are essential in the acceptance by investors of new radiopharmaceuticals: the
existence of a market and a medical need, the quality of the science and technology behind …

The growing interest in targeted radionuclide therapy (TRT) for a broad range of applications
is shared by a diverse group of medical professionals, including but not limited to physicians …

At present, the feature extraction method of radiology is mainly based on static tomography
images at a certain time. However, the occurrence and development of disease is a dynamic …

There has been much consternation in the nuclear medicine (NM) community in recent
years regarding the difficulty many NM graduates experience in securing initial employment …

In 2015, the Society of Nuclear Medicine and Molecular Imaging Technologist Section
(SNMMI-TS) launched a multiyear quality initiative to help prepare the technologist …

Aim: The aim was to ascertain the cost of diagnostic procedures conducted at the NM
Department of a tertiary health care facility by employing activity based costing (ABC) …

In their recent article, Graham, Delbeke, and Jadvar offer convincing data to support “a
steady downward spiral for nuclear medicine” over the last two decades. However, without …

The issue of what may constitute optimal training pathways for nuclear medicine and
molecular imaging has been of major interest and discussion over the past decade (1–7) …

Radiopharmaceuticals (RPhs) are unique pharmaceuticals which contain radioisotopes
which emit ionizing radiation. Depending on the nature of the radioisotope and application …